# Nutex Health Inc.: Form 10-Q for the period ended Jun 30, 2015

- Company: [Nutex Health Inc.](/companies/nutx.md) (CIK 1479681)
- Form: 10-Q
- Filed: 2015-08-18
- Accepted by EDGAR: Aug 18, 2015, 13:09 ET
- Period: 2015-06-30
- Accession: 0001211524-15-000112
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479681/000121152415000112/igambitform_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479681/000121152415000112/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-04-01 to 2015-06-30 | $347.8k | us-gaap:SalesRevenueNet |
| Revenue | 6 months, 2015-01-01 to 2015-06-30 | $648.1k | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2015-04-01 to 2015-06-30 | $167.4k | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2015-01-01 to 2015-06-30 | $303.1k | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2015-04-01 to 2015-06-30 | $180.3k | us-gaap:GrossProfit |
| Gross profit | 6 months, 2015-01-01 to 2015-06-30 | $345.0k | us-gaap:GrossProfit |
| Operating income | 3 months, 2015-04-01 to 2015-06-30 | −$48.5k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2015-01-01 to 2015-06-30 | −$191.7k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-04-01 to 2015-06-30 | −$3.1k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2015-01-01 to 2015-06-30 | −$4.8k | us-gaap:InterestExpense |
| Net income | 3 months, 2015-04-01 to 2015-06-30 | −$51.6k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2015-01-01 to 2015-06-30 | −$196.5k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-04-01 to 2015-06-30 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2015-01-01 to 2015-06-30 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months, 2015-04-01 to 2015-06-30 | 26,874,100 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2015-01-01 to 2015-06-30 | 26,729,846 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2015-01-01 to 2015-06-30 | −$119.9k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2015-01-01 to 2015-06-30 | −$5.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2015-06-30 | $41.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-06-30 | $249.0k | us-gaap:AssetsCurrent |
| Total assets | at 2015-06-30 | $271.9k | us-gaap:Assets |
| Current liabilities | at 2015-06-30 | $341.0k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2015-06-30 | −$69.0k | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 20,709 characters.

### Operations

### FORWARD LOOKING STATEMENTS

This Form 10-Q includes “forward-looking statements” within the meaning of Section 27A

of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of

1934, as amended. All statements, other than statements of historical facts, included or

incorporated by reference in this Form 10-Q which address activities, events or developments that

the Company expects or anticipates will or may occur in the future, including such things as future

capital expenditures (including the amount and nature thereof), finding suitable merger or

acquisition candidates, expansion and growth of the Company’s business and operations, and other

such matters are forward-looking statements. These statements are based on certain assumptions

and analyses made by the Company in light of its experience and its perception of historical trends,

current conditions and expected future developments as well as other factors it believes are

appropriate in the circumstances.

Investors are cautioned that any such forward-looking statements are not guarantees of

future performance and involve significant risks and uncertainties, and that actual results may

differ materially from those projected in the forward-looking statements. Factors that could

adversely affect actual results and performance include, among others, potential fluctuations in

quarterly operating results and expenses, government regulation, technology change and

competition. Consequently, all of the forward-looking statements made in this Form 10-Q are

qualified by these cautionary statements and there can be no assurance that the actual results or

developments anticipated by the Company will be realized or, even if substantially realized, that

they will have the expected consequence to or effects on the Company or its business or operations.

The Company assumes no obligations to update any such forward-looking statements.

### CRITICAL ACCOUNTING ESTIMATES

Our management’s discussion and analysis of our financial condition and results of

operations are based on our financial statements, which have been prepared in accordance with

accounting principles generally accepted in the United States of America. The preparation of

financial statements may require us to make estimates and assumptions that may affect the reported

amounts of assets and liabilities and the related disclosures at the date of the financial statements.

We do not currently have any estimates or assumptions where the nature of the estimates or

assumptions is material due to the levels of subjectivity and judgment necessary to account for

highly uncertain matters or the susceptibility of such matters to change or the impact of the

estimates and assumptions on financial condition or operating performance is material, except as

described below.

### Revenue Recognition

Our revenues from continuing operations consist of revenues derived primarily

from sales of products and services rendered to real estate brokers. We recognize revenues when

the services or products have been provided or delivered, the fees we charge are fixed or determinable, we and our customers understand the specific nature and terms of the agreed upon transactions, and collectability is reasonably assured.

### Cash and Cash Equivalents

For purposes of reporting cash flows, cash and cash equivalents include checking and

money market accounts and any highly liquid debt instruments purchased with a maturity of three

months or less.

### Accounts Receivable

We analyze the collectability of accounts receivable from continuing operations each

accounting period and adjust our allowance for doubtful accounts accordingly. A considerable

amount of judgment is required in assessing the realization of accounts receivables, including the

creditworthiness of each customer, current and historical collection history and the related aging

of past due balances. We evaluate specific accounts when we become aware of information

indicating that a customer may not be able to meet its financial obligations due to deterioration of

its financial condition, lower credit ratings, bankruptcy or other factors affecting the ability to

render payment. There was no bad debt expense charged to operations for six months ended June

30, 2015 and 2014, respectively.

### Property and equipment and depreciation

Property and equipment are stated at cost. Depreciation for both financial reporting and

income tax purposes is computed using combinations of the straight line and accelerated methods

over the estimated lives of the respective assets. Computer equipment is depreciated over 5 years

and furniture and fixtures are depreciated over 7 years. Maintenance and repairs are charged to

expense when incurred. When property and equipment are retired or otherwise disposed of, the

related cost and accumulated depreciation are removed from the respective accounts and any gain

or loss is credited or charged to income.

Depreciation expense of $2,611 and $2,383 was charged to operations for the six months

ended June 30, 2015 and 2014, respectively.

### Stock-Based Compensation

We account for our stock-based awards granted under our employee compensation plan in

accordance with ASC Topic No. 718-20, *Awards Classified as Equity,* which requires the

measurement of compensation expense for all share-based compensation granted to employees

and non-employee directors at fair value on the date of grant and recognition of compensation

expense over the related service period for awards expected to vest. We use the Black-Scholes

option valuation model to estimate the fair value of our stock options and warrants. The Black-

Scholes option valuation model requires the input of highly subjective assumptions including the

expected stock price volatility of the Company’s common stock. Changes in these subjective input

assumptions can materially affect the fair value estimate of our stock options and warrants.

### Income Taxes

We account for income taxes using the asset and liability method in accordance with ASC

Topic No. 740, Income Taxes. Under this method, deferred tax assets and liabilities are determined

based on differences between financial reporting and tax bases of assets and liabilities, and are

measured using the enacted tax rates and laws that are expected to be in effect when the differences

are expected to reverse.

We apply the provisions of ASC Topic No. 740 for the financial statement recognition,

measurement and disclosure of uncertain tax positions recognized in the Company’s financial

statements. In accordance with this provision, tax positions must meet a more-likely-than-not

recognition threshold and measurement attribute for the financial statement recognition and

measurement of a tax position. Management has determined that the Company has no significant

uncertain tax positions requiring recognition and measurement under ASC 740-10.

### Convertible Note

On September 16, 2013, we issued an 8% convertible note in the aggregate principal

amount of $103,500, convertible into shares of the Company’s common stock. The Note,

including accrued interest is due June 18, 2014 and is convertible any time after 180 days at the

option of the holder into shares of our common stock at 55% of the average stock price of the

lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading

day prior to the conversion date. Interest expense on the convertible note of $3,242 was recorded

for the year ended December 31, 2014.

Initially we anticipated repaying the obligation prior to the effective date of the holder electing to

convert. Since the effective date of the election to convert has passed we recorded a debt discount

related to identified embedded derivatives relating to conversion features and a reset provisions

based fair values as of the inception date of the Note. The calculated debt discount equaled the

face of the note and was amortized over the term of the note. During the year ended December

31, 2014, we amortized $63,250 of debt discount. During the year ended December 31, 2014, the

noteholder converted $49,000 of the principal balance to 1,539,934 shares of common stock, and

we repaid the remaining note balance of $54,500 and accrued interest of $5,646 on June 18, 2014.

### Derivative Liability

During the year ended December 31, 2013, we issued a convertible note.

The note is convertible into common stock, at the holders’ option, at a discount to the

market price of our common stock. We identified embedded derivatives included in these notes as

a result of certain anti-dilutive (reset) provisions, related to certain conversion features. The

accounting treatment of derivative financial instruments requires that we record the fair value of

the derivatives as of the inception date of the convertible note and debt discount amortization to

fair value as of each subsequent reporting date. This resulted in a fair value of derivative liability

of $152,076 in which to the extent of the face value of convertible note was treated as debt discount

with the remainder treated as interest expense.

The fair value of the embedded derivatives at December 31, 2013, in the amount of $152,076, was

determined using the Binomial Option Pricing Model based on the following assumptions: (1)

dividend yield of 0%; (2) expected volatility of 243.00%, (3) weighted average risk-free interest

rate of 0.09%, (4) expected lives of 0.72 to 0.75 years, and (5) estimated fair value of our common

stock of $0.51 per share. We recorded interest expense from the excess of the derivative liability

over the convertible note of $48,576 during the year ended December 31, 2013. We recorded a

gain on derivative liability of $152,076 during the year ended December 31, 2014 for the

satisfaction of the convertible note.

Based upon ASC 840-15-25 (EITF Issue 00-19, paragraph 11) we adopted a sequencing

approach regarding the application of ASC 815-40 to its outstanding convertible note. Pursuant to

the sequencing approach, we evaluate its contracts based upon earliest issuance date.

### MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

### RESULTS OF OPERATIONS

### INTRODUCTION

iGambit is a company focused on the technology markets. Our sole operating subsidiary,

Gotham Innovation Lab, Inc., is in the business of providing media technology services to the real

estate industry. We are focused on expanding the operations of Gotham by marketing the company

to existing and potential new clients.

***Assets.*** At June 30, 2015, we had $271,939 in total assets, compared to $280,786 at

December 31, 2014. The increase in total assets was primarily due to the increase in accounts

receivable and an increase in prepaid expenses.

***Liabilities.*** At June 30, 2015, our total liabilities were $340,975 compared to $285,277 at

December 31, 2014. Liabilities consist of accounts payable of $308,539 and loans payable to

stockholders of $32,436, whereas our total liabilities as of December 31, 2014 consisted of

accounts payable of $285,277. We do not have any long term liabilities.

***Stockholders’*** Deficiency. Our stockholders’ deficiency increased to $69,036 at June 30,

2015 from $4,491 at December 31, 2014. This increase was primarily due to an increase in

accumulated deficit from $(2,882,199) at December 31, 2014 to $(3,078,742) at June 30, 2015,

resulting from losses from operations of $(196,543) for the six months ended June 30, 2015.

### THREE MONTHS ENDED JUNE 30, 2015 AS COMPARED TO THREE MONTHS

### ENDED JUNE 30, 2014

***Revenues*** and Net Loss. We had $347,767 of revenue and a net loss of $51,646 during the

three months ended June 30, 2015 compared to revenue of $310,424 and a net loss of $75,270

during the three months ended June 30, 2014. The increase in revenue and decrease in net losses

was due to an increase in revenue generated by our Gotham subsidiary and a decrease in general

and administrative expenses. We also earned other income of $0 for the three months ended June

30, 2015, compared to other income of $119,805 for the three months ended June 30, 2014

primarily due to the gain on derivative liability. In addition to Gotham’s operations, we had income

from discontinued operations of $0 and $6,176 for the three months ended June 30, 2015 and June

30, 2014, respectively.

***General*** and Administrative Expenses. General and Administrative Expenses decreased

to $228,828 for the three months ended June 30, 2015 from $387,972 for the three months ended

June 30, 2014. For the three months ended June 30, 2015 our General and Administrative

Expenses consisted of corporate administrative expenses of $42,853, rent expense of $16,845,

employee benefits, consisting primarily of health insurance expense of $10,414, legal and

accounting fees of $24,569, business insurance expenses of $11,655, finders fees and commissions

of $17,500, investor relations expenses of $9,649, and payroll expenses of $95,343. For the three

months ended June 30, 2014 our General and Administrative Expenses consisted of corporate

administrative expenses of $68,022, rent expense of $16,997, legal and accounting fees of $12,628,

employee benefits, consisting primarily of health insurance expense of $15,416, consulting fees of

$26,106, payroll expenses of $198,024 and a bad debt write off of $50,779 as part of a settlement

for the receivable balance on the IGX rescission agreement. The decreases from the three months

ended June 30, 2014 to the three months ended June 30, 2014 relate primarily to: (i) a decrease in

payroll expenses; (ii) a decrease in rent; and (iii) a decrease in general and administrative costs

associated with the operation of our Gotham subsidiary. Costs associated with our officers’ salaries

and the operation of our Gotham subsidiary should remain level going forward, subject to a

material expansion in the business operations of Gotham which would likely increase our corporate

administrative expenses.

***Other*** Income (Expense) and Taxes. We had interest expense of $3,141 for the three

months ended June 30, 2015 compared to other income of $119,805 for the three months ended

June 30, 2014, primarily due to the gain on derivative liability.

### Six Months Ended June 30, 2015 as Compared to Six Months Ended June 30, 2014

***Revenues and Net Loss.*** We had $648,114 of revenue and a net loss of $196,543 during the six

months ended June 30, 2015, as compared to $550,637 of revenue and a net loss of $236,8448

during the six months ended June 30, 2014. The increase in revenue and decrease in net losses

was due to an increase in revenue generated by our acquired subsidiary Gotham and a decrease in

general and administrative expenses.

***General*** and Administrative Expenses. General and Administrative Expenses decreased to

$536,747 for the six months ended June 30, 2015 from $660,239 for the six months ended June

30, 2014. For the six months ended June 30, 2015 our General and Administrative Expenses

consisted of corporate administrative expenses of $107,752, rent expense of $34,118, employee

benefits, consisting primarily of health insurance expense of $18,102, legal and accounting fees of

$64,649, business insurance expenses of $23,990, consulting fees of $14,498, finders fees and

commissions of $17,500, investor relations expenses of $9,649, filing fees of $10,105, and payroll

expenses of $236,384. For the six months ended June 30, 2014 our General and Administrative

Expenses consisted of corporate administrative expenses of $110,176, rent expense of $34,453,

employee benefits, consisting primarily of health insurance expense of $37,338, legal and

accounting fees of $48,964, business insurance expenses of $23,500, consulting fees of $26,106,

payroll expenses of $328,923, and a bad debt write off of $50,779 as part of a settlement for the

receivable balance on the IGX rescission agreement. The decreases from the six months ended

June 30, 2014 to the six months ended June 30, 2015 relate primarily to a decrease in payroll

expense, health benefits and corporate administrative expenses. Costs associated with our officers’

salaries and the operation of our Gotham subsidiary should remain level going forward, subject to

a material expansion in the business operations of Gotham which would likely increase our

corporate administrative expenses.

***Other*** Income (Expense) and Taxes. We had interest expense of $4,844 for the three months

ended June 30, 2015 compared to other income of $81,838 primarily due to the gain on derivative

liability for the six months ended June 30, 2014.

### LIQUIDITY AND CAPITAL RESOURCES

### General

As reflected in the accompanying consolidated financial statements, at June 30, 2015, we

had $40,976 of cash and stockholders’ deficiency of $69,036 as compared to $133,436 of cash and

stockholders’ deficiency of $4,491 at December 31, 2014.

Our primary capital requirements in 2015 are likely to arise from the expansion of our

Gotham operations, and, in the event we effectuate an acquisition, from: (i) the amount of the

purchase price payable in cash at closing, if any; (ii) professional fees associated with the

negotiation, structuring, and closing of the transaction; and (iii) post-closing costs. It is not possible

to quantify those costs at this point in time, in that they depend on Gotham’s business opportunities,

the state of the overall economy, the relative size of any target company we identify and the

complexity of the related acquisition transaction(s). We anticipate raising capital in the private

markets to cover any such costs, though there can be no guaranty we will be able to do so on terms

we deem to be acceptable. We do not have any plans at this point in time to obtain a line of credit

or other loan facility from a commercial bank.

While we believe in the viability of our strategy to improve Gotham’s sales volume and to

acquire companies, and in our ability to raise additional funds, there can be no assurances that we

will be able to fully effectuate our business plan.

We believe we will continue to increase our cash position and liquidity for the foreseeable

future. We believe we have enough capital to fund our present operations.

### Cash Flow Activity

Net cash used by continuing operating activities was $119,870 for the six months ended

June 30, 2015, compared to net cash provided by operating activities of $618,957 for the six

months ended June 30, 2014. Our primary source of operating cash flows from continuing

operating activities for the six months ended June 30, 2015 was from our Gotham subsidiary’s

revenues of $648,114 and $550,637 for the six months ended June 30, 2015 and 2014, respectively.

Additional contributing factors to the change were from an increase in accounts receivable of

$25,860, an increase in prepaid expenses of $55,338, and an increase in accounts payable of

$23,262. Net cash provided by discontinued operating activities was $0 for the six months ended

June 30, 2015 and cash provided by discontinued operating activities was $655,746 for the six

months ended June 30, 2014. Cash provided by discontinued operations for the six months ended

June 30, 2014 consisted of $655,746 in cash payments received from DDC against accounts

receivable included in the Assets from Discontinued Operations.

Cash used by investing activities was $5,026 for the six months ended June 30, 2015

compared to cash used by investing activities of $4,738 for the six months ended June 30, 2014.

For the six months ended June 30, 2015 the use of cash used in investing activities was from the

purchase of property and equipment. For the six months ended June 30, 2014 the primary use of

cash in investing activities was from purchases of property and equipment of $2,026 and an

increase in deposits of $2,712.

Cash provided by financing activities was $32,436 for the six months ended June 30, 2015

compared to cash used by financing activities of $(51,400) for the six months ended June 30, 2014.

The cash flows provided by financing activities for the six months ended June 30,2015 was from

stockholder loans and the cash flows used by financing activities for the six months ended June

30, 2014 was primarily from repayment of the convertible note payable.

### Supplemental Cash Flow Activity

In the six months ended June 30, 2015 the company paid interest of $4,844 compared to

interest of $6,988 in the six months ended June 30, 2014.

## Controls and procedures

As filed, 918 characters.

### Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

We carried out an evaluation, as required by paragraph (b) of Rule 13a-15 and 15d-15 of

the Exchange Act under the supervision and with the participation of our management, including

our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure

controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as

of June 30, 2012. Based upon that evaluation, our Chief Executive Officer and Chief Financial

Officer concluded that our disclosure controls and procedures were effective as of June 30, 2015.

### Change in Internal Controls

During the six months ended June 30, 2015, there were no changes in our internal control

over financial reporting that materially affected, or are reasonably likely to materially affect, our

internal control over financial reporting.

Filed Aug 18, 2015.
Source: SEC EDGAR, the filing index for accession 0001211524-15-000112. Last ingested by Listed: Nov 14, 2026, 12:46 ET. No prices; not investment advice.
